ERBB2 and neoplasm: In agreement with our previous results, we found that F/B from tumor-stroma interface (7.26 ± 0.49) is significantly higher than F/B from tumor bulk (5.25 ± 0.36) in HER2+ core needle biopsies (paired t-test, p = 0.0003, Figure 2a).